CRBP · Corbus Pharmaceuticals Holdings, Inc. · Documents
$4.39
-0.04 (-0.79%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$85.49M
Shares
19.34M
Volume · Oct 21
440.31K
Avg daily vol (3M)
828.37K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Corbus Pharmaceuticals reported CRB-701 2L OPSCC data of 43% ORR at 3.6 mg/kg; TEMPO-1 began in Sept. 2026, with 1L data expected Q1 2027 and potential BLA filing in 2H 2028. CRB-913 achieved 5% placebo adjusted weight loss in Phase 1b at 12 weeks. | 2026-10-15 | — | |
| 8-K | — | 2026-09-14 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-08-06 | — | |
| 8-K | — | 2026-07-06 | 2026-07-02 | |
| Investor Event Transcript | — | 2026-06-04 | 2026-06-30 | |
| 8-K | — | 2026-05-26 | — | |
| Investor Event Transcript | — | 2026-05-26 | 2026-06-30 | |
| 8-K | — | 2026-05-21 | 2026-05-19 | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| 8-K | — | 2026-05-14 | 2026-05-13 | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| 8-K | — | 2026-05-12 | — | |
| 8-K | — | 2026-04-16 | 2026-04-15 | |
| DEFA14A | — | 2026-04-16 | — | |
| 8-K | — | 2026-04-14 | — | |
| 8-K | — | 2026-04-07 | 2026-04-01 | |
| DEF 14A | — | 2026-04-02 | 2026-04-01 | |
| DEFA14A | — | 2026-04-02 | — | |
| S-3 | — | 2026-03-11 | — | |
| 8-K | — | 2026-03-09 | — | |
| 10-K | — | 2026-03-09 | 2025-12-31 | |
| 8-K | — | 2026-02-25 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-12-18 | 2025-12-12 | |
| 8-K | — | 2025-12-11 | — | |
| 8-K | — | 2025-11-12 | — | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 8-K | — | 2025-11-03 | 2025-10-30 | |
| 8-K | — | 2025-10-30 | — | |
| 8-K | — | 2025-10-20 | 2025-10-18 | |
| 8-K | — | 2025-09-16 | — | |
| 10-Q | — | 2025-08-05 | 2025-06-30 | |
| 8-K | — | 2025-08-05 | — | |
| 8-K | — | 2025-05-19 | 2025-05-15 | |
| 8-K | — | 2025-05-06 | — | |
| 10-Q | — | 2025-05-06 | 2025-03-31 | |
| DEF 14A | — | 2025-04-01 | 2025-05-15 | |
| DEFA14A | — | 2025-04-01 | — | |
| 8-K | — | 2025-03-21 | 2025-03-20 | |
| 8-K | — | 2025-03-18 | 2025-03-13 | |
| 10-K | — | 2025-03-11 | 2024-12-31 | |
| 8-K | — | 2025-03-11 | — | |
| 8-K | — | 2025-02-14 | — | |
| 8-K | — | 2024-12-03 | — | |
| 8-K | — | 2024-11-15 | — | |
| 8-K | — | 2024-11-07 | — | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| 8-K | — | 2024-11-04 | — | |
| 8-K | — | 2024-09-03 | 2024-08-29 |
Showing 1–50 of 169 filings
Key facts
CIK
1595097
CUSIP
21833P301
13F (30d)
13 filings
13 filers
Visit website
Investor relations